ANU POLICHERLA: Open Payments
NPI 1710660949 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 11 payments from 9 companies in 2025. Trend: 2023 $282 · 2024 $0 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $229 |
| SANOFI-AVENTIS U.S. LLC | 2 | $188 |
| Neurelis, Inc. | 1 | $115 |
| Insmed, Inc. | 1 | $112 |
| Axsome Therapeutics, Inc. | 1 | $109 |
| Novo Nordisk Inc | 1 | $105 |
| Alexion Pharmaceuticals, Inc. | 1 | $104 |
| Lilly USA, LLC | 1 | $89 |
| GENZYME CORPORATION | 1 | $84 |
Products named: AUSTEDO XR, TZIELD, VALTOCO, Arikayce, Auvelity, Wegovy, ZEPBOUND, DUPIXENT.
Industry payments across AR — which companies pay providers there.
